Overexpression of HER2/neu oncogene in human pancreatic carcinoma
1993 · Human Pathology · 214 citations
https://doi.org/10.1016/0046-8177(93)90194-l
H
Helmut Friess
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
620
Papers
28.9K
Citations
91
h-index
309
i10-index
Helmut Friess is an academic researcher from Munich University of Applied Sciences. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Pancreatitis Pathology and Treatment & Neuroendocrine Tumor Research Advances. The author has an h-index of 91, co-authored 527 publications.
Papers by this author
worksExpression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma
2005 · International Journal of Cancer · 193 citations
https://doi.org/10.1002/ijc.20831
Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis
2018 · Pancreatology · 164 citations
https://doi.org/10.1016/j.pan.2018.09.016
Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)—a randomized phase II trial of the AIO pancreatic cancer group
2022 · Annals of Oncology · 146 citations
https://doi.org/10.1016/j.annonc.2022.09.161
Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancer
2007 · British Journal of Cancer · 72 citations
https://doi.org/10.1038/sj.bjc.6603984
Randomized phase II – study evaluating EGFR targeting therapy with Cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer – PARC: study protocol [ISRCTN56652283]
2005 · BMC Cancer · 69 citations
https://doi.org/10.1186/1471-2407-5-131
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat